Completed
Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults
NCT00975884
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Clermont-Ferrand, France
- GSK Investigational Site Lille, France
- GSK Investigational Site Paris, France
- GSK Investigational Site Paris, France